Cargando…
PDGFR-alpha inhibits melanoma growth via CXCL10/IP-10: a multi-omics approach
Melanoma is the most aggressive skin-cancer, showing high mortality at advanced stages. Platelet Derived Growth Factor Receptor-alpha (PDGFR-alpha) potently inhibits melanoma- and endothelium-proliferation and its expression is significantly reduced in melanoma-biopsies, suggesting that melanoma pro...
Autores principales: | D'Arcangelo, Daniela, Facchiano, Francesco, Nassa, Giovanni, Stancato, Andrea, Antonini, Annalisa, Rossi, Stefania, Senatore, Cinzia, Cordella, Martina, Tabolacci, Claudio, Salvati, Annamaria, Tarallo, Roberta, Weisz, Alessandro, Facchiano, Angelo M., Facchiano, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363585/ https://www.ncbi.nlm.nih.gov/pubmed/27764787 http://dx.doi.org/10.18632/oncotarget.12629 |
Ejemplares similares
-
TNF-alpha and metalloproteases as key players in melanoma cells aggressiveness
por: Rossi, Stefania, et al.
Publicado: (2018) -
Melanoma Cell Resistance to Vemurafenib Modifies Inter-Cellular Communication Signals
por: Tabolacci, Claudio, et al.
Publicado: (2021) -
Differential Denaturation of Serum Proteome Reveals a Significant Amount of Hidden Information in Complex Mixtures of Proteins
por: Verdoliva, Vincenzo, et al.
Publicado: (2013) -
Identification of Dihydrolipoamide Dehydrogenase as Potential Target of Vemurafenib-Resistant Melanoma Cells
por: Tabolacci, Claudio, et al.
Publicado: (2022) -
Nicotinamide inhibits melanoma in vitro and in vivo
por: Scatozza, Francesca, et al.
Publicado: (2020)